Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

Presentation THT 2024

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT 2024

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

Presenter: Stavros G. Drakos

March 05, 2024

Presentation THT 2024

How to Manage VT in Advanced HF and Post-LVAD Patients

Presenter: Jakub Sroubek

March 05, 2024

Presentation THT 2024

Patient Identification and Post-implant Management within an Advanced Heart Failure Program

Presenter: Dmitry Yaranov

March 05, 2024

Presentation THT 2024

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Presenter: Lothar Roessig

March 05, 2024

Presentation THT 2024

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Presenter: Daniel Asemota

March 05, 2024

Presentation THT 2024

Advances in Hemocompatibility

Presenter: Mandeep R. Mehra

March 04, 2024

Presentation THT 2024

Durrable LVADs: Innovations in Programming and Management Required to Advance the Field

Presenter: Melana Yuzefpolskaya

March 04, 2024

Presentation THT 2024

Durable LVADs: Pump Innovations Required to Advance the Field

Presenter: Francis D. Pagani

March 04, 2024

Presentation THT 2024

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: William T. Abraham

March 04, 2024

Advertisement

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Cardiac Contractility Modulator as an Option for Advanced Heart Failure Patients Dependent on Low Dose inotropes

Derivation and Validation of a Multicenter Model to Identify Candidates for Advanced HF Therapies with High Potential to Achieve post-LVAD Reverse Cardiac Remodeling

How to Manage VT in Advanced HF and Post-LVAD Patients

Patient Identification and Post-implant Management within an Advanced Heart Failure Program

A Phase 1 Clinical Gene Therapy Trial in Patients With Advanced Heart Failure Using a Rationally Designed Cardiotropic AAV Vector Targeting Protein Phosphatase Inhibitor-1

Alternative Advanced Therapy: Case of Cardiac Contractility Modulation in Stage D Ischemic Cardiomyopathy

Advances in Hemocompatibility

Durrable LVADs: Innovations in Programming and Management Required to Advance the Field

Durable LVADs: Pump Innovations Required to Advance the Field

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content